NCT01385683View on ClinicalTrials.gov

Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Healthy
Interventions
DRUG

Dabigatran then dabigatran and clarithromycin

D4 : dabigatran 300 mg (4 tablets) one time. D8 to D10 : Clarithromycin 500mg (1 tablet) twice daily. D11 : Clarithromycin 500mg (1 tablet) + 300mg dabigatran (4 tablets)

DRUG

Clarithromycin and dabigatran then dabigatran

D1 to D3 : Clarithromycin 500mg (1 tablet) twice daily. D4 : Clarithromycin 500mg (1 tablet) + 300mg dabigatran (4 tablets). D11 : dabigatran 300 mg (4 tablets) one time.

Trial Locations (1)

42055

Service de Medecine et Therapeutique, Saint-Etienne

All Listed Sponsors
collaborator

Groupe de Recherche sur la Thrombose

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT01385683 - Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin | Biotech Hunter | Biotech Hunter